X-Chem, Inc.

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Astellas Taps Selecta For Gene The

Rising Leaders Home There is no age restriction to being included in the Rising Leaders list; the 30 people below were recognized for bringing something new to the game. The list focuses on achieveme

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Merck Inks Platform Licensing Agreement

Amylyx Pharmaceuticals, Inc. announced Phase II/III results for AMX0035 in the treatment of amyotrophic lateral sclerosis (ALS) last year and hoped to obtain US Food and Drug Administration approval